NCT03432247: Pain Management Support Study for Patients With Advanced Cancer

NCT03432247
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients with CNS metastatic disease that impairs concentration, memory, balance or focus
https://ClinicalTrials.gov/show/NCT03432247

Comments are closed.

Up ↑